The influence of ciprofloxacin on viability of A549, HepG2, A375.S2, B16 and C6 cell lines in vitro.

Kloskowski, Tomasz; Gurtowska, Natalia; Nowak, Monika; Joachimiak, Romana; Bajek, Anna; Olkowska, Joanna; Drewa, Tomasz

Kloskowski, Tomasz; Gurtowska, Natalia; Nowak, Monika; Joachimiak, Romana; Bajek, Anna; Olkowska, Joanna; Drewa, Tomasz.

Affiliation

Kloskowski T; Department of Tissue Engineering, Chair of Medical Biology, Nicolaus Copernicus University, Karlowicza 24, 85-092 Bydgoszcz, Poland. tomaszkloskowski@op.pl

Acta Pol Pharm ; 68(6): 859-65, 2011.

Article in En | MEDLINE | ID: mdl-22125950

Subject(s)

Ciprofloxacin/pharmacology; Neoplasms/pathology; Animals; Antineoplastic Agents/pharmacology; Brain Neoplasms/pathology; Carcinoma, Hepatocellular/pathology; Carcinoma, Non-Small-Cell Lung/pathology; Cell Shape/drug effects; Cell Survival/drug effects; Dose-Response Relationship, Drug; Glioblastoma/pathology; Hep G2 Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms/pathology; Lung Neoplasms/pathology; Melanoma, Experimental/pathology; Mice; Rats; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ciprofloxacin / Neoplasms Limits: Animals / Humans Language: En Journal: Acta Pol Pharm Year: 2011 Document type: Article Affiliation country: Poland

Search on Google

Add to My VHL

XML

PubMed Links